These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 26072398)

  • 1. Aptamer Targeting the ERBB2 Receptor Tyrosine Kinase for Applications in Tumor Therapy.
    Mahlknecht G; Sela M; Yarden Y
    Methods Mol Biol; 2015; 1317():3-15. PubMed ID: 26072398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multimerization of ERBB2/HER2 specific aptamer leads to improved receptor binding.
    Mahlknecht G; Maron R; Schechter B; Yarden Y; Sela M
    Biochem Biophys Res Commun; 2015 Sep; 465(2):218-24. PubMed ID: 26248137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection of DNA aptamers against VEGF165 using a protein competitor and the aptamer blotting method.
    Hasegawa H; Sode K; Ikebukuro K
    Biotechnol Lett; 2008 May; 30(5):829-34. PubMed ID: 18175068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection of aptamers for fluorescent detection of alpha-methylacyl-CoA racemase by single-bead SELEX.
    Yang DK; Chen LC; Lee MY; Hsu CH; Chen CS
    Biosens Bioelectron; 2014 Dec; 62():106-12. PubMed ID: 24994506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A simple method for eliminating fixed-region interference of aptamer binding during SELEX.
    Ouellet E; Lagally ET; Cheung KC; Haynes CA
    Biotechnol Bioeng; 2014 Nov; 111(11):2265-79. PubMed ID: 24895227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aptamer to ErbB-2/HER2 enhances degradation of the target and inhibits tumorigenic growth.
    Mahlknecht G; Maron R; Mancini M; Schechter B; Sela M; Yarden Y
    Proc Natl Acad Sci U S A; 2013 May; 110(20):8170-5. PubMed ID: 23630281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of an aptamer through whole cell-SELEX for targeting high metastatic liver cancers.
    Rong Y; Chen H; Zhou XF; Yin CQ; Wang BC; Peng CW; Liu SP; Wang FB
    Oncotarget; 2016 Feb; 7(7):8282-94. PubMed ID: 26882565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-SELEX-based selection of aptamers that recognize distinct targets on metastatic colorectal cancer cells.
    Li WM; Bing T; Wei JY; Chen ZZ; Shangguan DH; Fang J
    Biomaterials; 2014 Aug; 35(25):6998-7007. PubMed ID: 24857291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selection and characterization of DNA aptamers specific for Listeria species.
    Suh SH; Dwivedi HP; Choi SJ; Jaykus LA
    Anal Biochem; 2014 Aug; 459():39-45. PubMed ID: 24857773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficient cell-SELEX strategy, Icell-SELEX, using isogenic cell lines for selection and counter-selection to generate RNA aptamers to cell surface proteins.
    Takahashi M; Sakota E; Nakamura Y
    Biochimie; 2016 Dec; 131():77-84. PubMed ID: 27693080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Screening and characterization of DNA aptamers with hTNF-alpha binding and neutralizing activity].
    Guo KT; Yan XR; Huang GJ; Xu CX; Chai YS; Zhang ZQ
    Sheng Wu Gong Cheng Xue Bao; 2003 Nov; 19(6):730-3. PubMed ID: 15971588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selection and characterization of DNA aptamers against VEGF165 with aptamer blotting method and its application.
    Ikebukuro K; Hasegawa H; Sode K
    Nucleic Acids Symp Ser (Oxf); 2007; (51):399-400. PubMed ID: 18029755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of an enriched pool of DNA aptamers for an HER2-overexpressing cell line selected by Cell SELEX.
    Dastjerdi K; Tabar GH; Dehghani H; Haghparast A
    Biotechnol Appl Biochem; 2011; 58(4):226-30. PubMed ID: 21838796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection and Identification of Chloramphenicol-Specific DNA Aptamers by Mag-SELEX.
    Duan Y; Gao Z; Wang L; Wang H; Zhang H; Li H
    Appl Biochem Biotechnol; 2016 Dec; 180(8):1644-1656. PubMed ID: 27613616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide aptamers with binding specificity for the intracellular domain of the ErbB2 receptor interfere with AKT signaling and sensitize breast cancer cells to Taxol.
    Kunz C; Borghouts C; Buerger C; Groner B
    Mol Cancer Res; 2006 Dec; 4(12):983-98. PubMed ID: 17189388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selection of aptamers for molecular recognition and characterization of cancer cells.
    Tang Z; Shangguan D; Wang K; Shi H; Sefah K; Mallikratchy P; Chen HW; Li Y; Tan W
    Anal Chem; 2007 Jul; 79(13):4900-7. PubMed ID: 17530817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selection of DNA aptamers for extra cellular domain of human epidermal growth factor receptor 2 to detect HER2 positive carcinomas.
    Sett A; Borthakur BB; Bora U
    Clin Transl Oncol; 2017 Aug; 19(8):976-988. PubMed ID: 28224267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Capillary electrophoresis-SELEX selection of aptamers with affinity for HIV-1 reverse transcriptase.
    Mosing RK; Mendonsa SD; Bowser MT
    Anal Chem; 2005 Oct; 77(19):6107-12. PubMed ID: 16194066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection of a DNA aptamer that binds 8-OHdG using GMP-agarose.
    Miyachi Y; Shimizu N; Ogino C; Fukuda H; Kondo A
    Bioorg Med Chem Lett; 2009 Jul; 19(13):3619-22. PubMed ID: 19450981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is less more? Lessons from aptamer selection strategies.
    Szeitner Z; András J; Gyurcsányi RE; Mészáros T
    J Pharm Biomed Anal; 2014 Dec; 101():58-65. PubMed ID: 24877649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.